Views & Analysis Pharmacovigilance as a business enabler Industry may be limiting its options if safety takes a back seat to efficacy in trial design and product development.
News Better slashes staff in another digital health retreat Company will cut its headcount by 35%, as it waits for an FDA decision on its diabetes DTx.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
